Codes / ICD10CM / D09.22

D09.22 Carcinoma in situ of left eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Carcinoma in situ of left eye

Summary

Carcinoma in situ of the left eye is a non-invasive condition where abnormal cells are confined to the epithelial lining of the left eye without invading deeper tissues. These cells have the potential to become cancerous but have not yet spread. This is considered an early, localized form of cancer.

Causes

The exact cause is often unknown but may involve genetic mutations in ocular cells. Environmental factors, such as exposure to carcinogens or chronic inflammation, can also contribute to the development of these abnormal cells.

Risk Factors

  • Prolonged exposure to ultraviolet (UV) radiation.
  • Personal or family history of skin or ocular cancer.
  • Chronic eye conditions or inflammation.
  • Certain genetic syndromes that increase cancer risk.

Symptoms

  • Often asymptomatic and detected during routine eye exams.
  • Possible changes in the appearance of the eye surface, such as redness or lesions.
  • Visual disturbances, though rare.

Diagnosis

Carcinoma in situ of the left eye is diagnosed through a combination of clinical examination and biopsy. A slit-lamp examination allows for detailed visualization of the eye surface, while a biopsy of suspicious areas evaluates cellular abnormalities. Additional tests, such as imaging or cytology, may be used to confirm the diagnosis.

Treatment Options

  • Surgical excision of the affected tissue.
  • Cryotherapy (freezing) to destroy abnormal cells.
  • Topical medications, such as chemotherapy or immunotherapy agents.
  • Close monitoring with regular follow-up exams.

Prognosis and Follow-Up

The prognosis is generally favorable when treated early, as the condition is non-invasive. Regular follow-up appointments are essential to monitor for recurrence or progression. Long-term surveillance may be recommended to detect any changes in the eye.

Complications

  • Potential progression to invasive cancer if left untreated.
  • Recurrence of abnormal cells after treatment.
  • Rarely, visual impairment if the condition affects critical areas of the eye.

Lifestyle & Prevention

  • Protect the eyes from UV radiation by wearing sunglasses and hats.
  • Avoid exposure to known carcinogens or irritants.
  • Maintain regular eye exams, especially for those with risk factors.
  • Manage chronic eye conditions promptly to reduce inflammation.

When to Seek Professional Help

Seek medical attention if you notice persistent changes in the eye, such as redness, lesions, or visual disturbances. Routine eye exams are also important for early detection, particularly for individuals with risk factors.

Tips for Medical Coders

When coding for carcinoma in situ of the left eye (D09.22), ensure the laterality (left eye) is clearly documented. Verify that the diagnosis aligns with clinical findings, such as biopsy results or imaging, to support the code assignment. Document the specific location within the eye if available, as this may impact coding specificity.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

D09.22 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.